REPORT ID 231

Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report Forecast 2017-2021

Publish Date
25-Dec-17
Pages
100
Format
Electronic (PDF)

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape. 

The study is a source of reliable data on:
Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:
Conatus Pharmaceuticals
Daewoong Pharmaceutical
Galmed International
Kyorin Pharmaceutical
Metabolic Solutions Development
Novartis AG
Phenex Pharmaceuticals
Raptor Pharmaceuticals
TCM Biotech International
...

Product Segment Analysis:
Type 1
Type 2
Type 3 

Application Segment Analysis:
Application 1
Application 2
Application 3 

Reasons for Buying this Report
This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth 
It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
It helps in understanding the key product segments and their future
It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
It provides distinctive graphics and exemplified analysis of major market segments 
			   
Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Market Report Forecast 2017-2021

1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Overview
1.1 Product Overview and Scope of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Classification of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2.1 Type 1
1.2.2 Type 2
1.2.3 Type 3
1.3 Application of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.3.2 Application 1 
1.3.3 Application 2
1.3.4 Application 3
1.4 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market States Status and Prospect (2012-2021) by Regions
1.4.1 United States
1.4.2 China
1.4.3 Europe
1.4.4 Japan
1.5 Global Market Size of Non-alcoholic Fatty Liver Disease (NAFLD) Drug (2012-2021)
1.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2021)
1.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2021)

2 Global Economic Impact on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
2.1 Global Macroeconomic Environment Analysis
2.1.1 Global Macroeconomic Analysis
2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Cost Analysis
3.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Raw Materials Analysis
3.1.1 Key Raw Materials
3.1.2 Price Trend of Key Raw Materials
3.1.3 Key Suppliers of Raw Materials
3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
3.2.1 Raw Materials
3.2.2 Labor Cost
3.2.3 Manufacturing Process Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug

4 Industrial Chain, Sourcing Strategy and Downstream Buyers
4.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Competition by Manufacturers, Type and Application
5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Competition by Manufacturers
5.1.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share of Key Manufacturers (2012-2017)
5.1.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Type
5.5.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type (2012-2017)
5.5.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume and Value) by Regions
5.3.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Regions (2012-2017)
5.3.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume) by Application

6 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
6.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
6.1.1 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
6.1.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
6.1.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
6.2 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
6.3 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
6.4 United States Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

7 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
7.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
7.1.1 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
7.1.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
7.1.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
7.2 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
7.3 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
7.4 China Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

8 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
8.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
8.1.1 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
8.1.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
8.1.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
8.2 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
8.3 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
8.4 Europe Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

9 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug (Volume, Value and Sales Price)
9.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Value (2012-2017)
9.1.1 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Growth Rate (2012-2017)
9.1.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Revenue and Growth Rate (2012-2017)
9.1.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Price Trend (2012-2017)
9.2 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Manufacturers
9.3 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Type
9.4 Japan Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales and Market Share by Application

10 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Analysis
10.1 Conatus Pharmaceuticals
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Product Type, Application and Specification
10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Business Overview
10.2 Daewoong Pharmaceutical
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Product Type, Application and Specification
10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Business Overview
10.3 Galmed International
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Product Type, Application and Specification
10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Business Overview
10.4 Kyorin Pharmaceutical
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Product Type, Application and Specification
10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Business Overview
10.5 Metabolic Solutions Development
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Product Type, Application and Specification
10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Business Overview
10.6 Novartis AG
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Product Type, Application and Specification
10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Business Overview
10.7 Phenex Pharmaceuticals
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Product Type, Application and Specification
10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Business Overview
10.8 Raptor Pharmaceuticals
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Product Type, Application and Specification
10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Business Overview
10.9 TCM Biotech International
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Product Type, Application and Specification
10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Business Overview
...

11 Marketing Strategy Analysis, Distributors/Traders
11.1 Marketing Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
11.2.1 Pricing Strategy
11.2.2 Brand Strategy
11.2.3 Target Client
11.3 Distributors/Traders List

12 Market Effect Factors Analysis
12.1 Technology Progress/Risk
12.1.1 Substitutes Threat
12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Forecast (2017-2021)
13.1 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales, Revenue Forecast (2017-2021)
13.2 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Regions (2017-2021)
13.3 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Type (2017-2021)
13.4 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Sales Forecast by Application (2017-2021)

14 Appendix